Parnassus Investments released its Q2 2025 investor letter, reporting a 7.24% net return, outperforming the Russell 1000 Value Index at 3.79%. Top 5 holdings listed. Pfizer Inc. (NYSE:PFE) saw a 1.73% rise in the past month but lost 13.36% in the last 12 months, closing at $24.65 on August 12, 2025, with a market cap of $140.1 billion. The firm exited its position in Pfizer due to weakened research pipeline and potential M&A activities.

Pfizer Inc. (NYSE:PFE) is not among the 30 most popular stocks among hedge funds but 99 hedge fund portfolios held positions in Q1 2025, up from 92 in the previous quarter. PFE beat earnings expectations with an EPS of $0.78. While PFE has investment potential, certain AI stocks offer greater upside with less downside risk. Check out our free report for more insights. Jim Cramer’s views on Pfizer can be found in another article.

For more investor letters from hedge funds and leading investors, visit our hedge fund investor letters Q2 2025 page. Explore the best and worst Dow stocks for the next 12 months and 10 unstoppable stocks that could double your money. This article was originally published on Insider Monkey.

Read more at Yahoo Finance: Should You Now Consider Selling Your Pfizer (PFE) Shares Before its Too Late?